NomosLogic

Privacy Policy

NomosLogic Master Policy Agreement

Effective Date: January 1, 2026 · Version 1.0

1. Data Privacy & Sovereign Ownership

You remain the sole owner of your raw genetic data (SNPs) and metabolic biomarkers. NomosLogic acts as a data custodian with no ownership claims.

We do not, and will never, sell, lease, or rent individual-level health data to pharmaceutical companies, insurance providers, or third-party advertisers without explicit opt-in.

Upon deletion, identifiable genetic data is purged within thirty days per the Delaware Personal Data Privacy Act.

2. HIPAA & Security Standards

All data is encrypted with AES-256 at rest and TLS 1.2+ in transit. Data used for system improvement is stripped of PII and assigned non-referential UUIDs.

NomosLogic voluntarily adheres to HIPAA Security and Privacy Rules for Protected Health Information.

3. Medical Disclaimers & Use of AI

The platform provides Actionable Intelligence for wellness purposes. It does not constitute medical diagnoses or treatment recommendations. Use does not establish a professional health relationship.

Users must consult licensed physicians before making changes to diet, medication, or exercise based on platform findings.

4. Data Usage & Ingestion

Uploading lab PDFs or connecting EHR authorizes Biomarker Analysis Module parsing. Wearable connections (Apple Health, Oura) are optional and revocable through settings.

5. Limitation of Liability & Indemnity

NomosLogic is not liable for indirect, incidental, or consequential damages arising from platform use. Users indemnify the company from claims arising from agreement breach or misuse.

6. Mandatory Arbitration & Class Action Waiver

Disputes shall be resolved through binding arbitration in Salt Lake City, Utah or Wilmington, Delaware. Users waive the right to participate in class-action lawsuits or class-wide arbitration.

7. Governing Law

This agreement is governed by the laws of the State of Delaware without regard to conflict of law principles.